Indium in-111 pentetreotide kit - Generic Drug Details

What are the generic sources for indium in-111 pentetreotide kit and what is the scope of freedom to operate?

Indium in-111 pentetreotide kit is the generic ingredient in one branded drug marketed by Curium and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for indium in-111 pentetreotide kit

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	5
Patent Applications:	67
DailyMed Link:	indium in-111 pentetreotide kit at DailyMed

Recent Clinical Trials for indium in-111 pentetreotide kit

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Hospital Inselspital, Berne	Phase 1/Phase 2
University Hospital, Basel, Switzerland	Phase 1/Phase 2
University of Lausanne Hospitals	Phase 1/Phase 2

See all indium in-111 pentetreotide kit clinical trials

US Patents and Regulatory Information for indium in-111 pentetreotide kit

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994		RX	Yes	Yes

Expired US Patents for indium in-111 pentetreotide kit

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994